Stockreport

Elevai Bioscience up on portfolio expansion with new filings for muscle loss treatment in obese patients [Seeking Alpha]

Elevai Labs, Inc.  (ELAB) 
PDF These patent applications cover both standalone and combination therapies using EL-22 alongside GLP-1 receptor agonists, marking a significant advancement in obesity tr [Read more]